LINDA ABRIEL: Open Payments
NPI 1770559627 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,482 in 51 payments from 16 companies in 2025. Trend: 2023 $1,018 · 2024 $1,277 · 2025 $1,482
Food & beverage: $1,470Education: $11
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $427 |
| COLOPLAST CORP | 12 | $208 |
| Sumitomo Pharma America, Inc. | 3 | $172 |
| 180 Medical, Inc. | 5 | $115 |
| Boston Scientific Corporation | 1 | $101 |
| Astellas Pharma US Inc | 3 | $98 |
| Merck Sharp & Dohme LLC | 3 | $74 |
| Endo USA, Inc. | 3 | $66 |
| ABBVIE INC. | 2 | $49 |
| TOLMAR, INC. | 2 | $40 |
Products named: RYBREVANT, GEMTESA, ERLEADA, Luja Coude, AMS 700, Xtandi, KEYTRUDA, SpeediCath.
Industry payments across NY — which companies pay providers there.
